// App-Quantinova.ai

: Hypodysfibrinogenemia in a Patient with Aortic Valve Thrombosis and Stroke: Diagnosis and Evolution. Identification of a Novel Heterozygous Fibrinogen Gamma Chain Mutation

Researchers

Presenter

  • V. Privitera

Principal Investigators

  • M. Neerman-Arbez

  • M. Martinuzzo

  • C.M. Rosa

  • A. Casini

  • R. Aguilar

  • M. Lpez

  • D. Mezzarobba

  • D. Penchasky

  • S. Viuales

  • L. Barrera

  • P. De Moerloose

  • J. Arbelbide

Medical Centers

  • Hospital Italiano de Buenos Aires, Capital Federal, Argentina

  • Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  • Hospital Italiano de Buenos Aires, Laboratorio Central, Capital Federal, Argentina

  • Instituto Universitario del Hospital Italiano, Bioquímica Aplicada, Buenos Aires, Argentina

  • Hospital Universitario Austral, Laboratorio y Servicio de Hematología, Pilar, Argentina

  • University Hospitals of Geneva, Angiology and Haemostasis, Geneva, Switzerland

  • Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

Locations

  • Argentina

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Stroke

Biomarkers

  • Fibrinogen

Drug/Treatment

  • Fibrinogen (IV)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved